Satellos Bioscience Inc. Stock: price and insider trades · Canada

Satellos Bioscience Inc. is a listed company. Its directors and officers file their transactions with SEDI. 7 insiders have disclosed 30 filings since 18 October 2025.

Only purchases show up on the open market, 24 purchases in all worth €276k, filed by 2 insiders. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 2 senior executives among the declarants. Biggest ticket of the year: €207k, bought by Berger, Franklin Milan and made public on 15 July 2026 (0.13% of market cap).

The last insider purchase was made public on 15 July 2026, 94 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. The shorter that gap, the sooner other investors can see what insiders have done.

For context, the typical company on the same exchange (median of 2,120 companies) published 12 filings over the same period, against 30 filings here. Over the whole record (from 2026), the tally stands at 24 purchases and no sales.

Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.